AYURVEDIC MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE A COMPARATIVE REVIEW OF SUDARSHAN GHANVATI AND AROGYVARDHNI VATI

Non-Alcoholic Fatty Liver Disease (NAFLD) is a growing global health concern characterized by excessive fat accumulation in the liver without significant alcohol consumption. It encompasses a spectrum ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), potentially progressing to cirrhosis and hepatocellular carcinoma. Modern therapeutic options for NAFLD are limited and primarily focus on lifestyle modification, highlighting the need for effective alternative treatments. Ayurveda, the ancient Indian system of medicine, offers a holistic approach to liver disorders, with several classical formulations reputed for their hepatoprotective and metabolic regulatory effects. Among these, Sudarshan Ghanvati and Arogyavardhani Vati have been traditionally employed for managing liver dysfunction and associated metabolic imbalances. This review compares the efficacy, pharmacodynamics, and clinical applications of Sudarshan Ghanvati and Arogyavardhani Vati in the management of NAFLD. Sudarshan Ghanvati, known for its Deepana (digestive stimulant), Pachana (digestive), and Pittashamak (anti-inflammatory) properties, aids in improving metabolism and reducing hepatic inflammation. Arogyavardhani Vati, containing a combination of herbs and mineral preparations, exhibits potent hepatoprotective, antioxidant, and lipid-lowering effects. Both formulations contribute to detoxification and metabolic homeostasis, albeit through differing mechanisms. By analyzing classical texts, clinical studies, and pharmacological data, this review highlights their therapeutic potential and safety profiles. It suggests that integrating these Ayurvedic formulations could provide a complementary approach to NAFLD management, warranting further clinical trials for standardized protocols and validation.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-05-01
DOI
https://doi.org/10.5281/zenodo.19908626
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

AYURVEDIC MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE A COMPARATIVE REVIEW OF SUDARSHAN GHANVATI AND AROGYVARDHNI VATI

Dr. Umesh Kumar Sapra2 Dr. Prahlad Kumar Prajapati*1
Zenodo (CERN European Organization for Nuclear Research)
Liver Disease Diagnosis and Treatment
article

AYURVEDIC MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE A COMPARATIVE REVIEW OF SUDARSHAN GHANVATI AND AROGYVARDHNI VATI

Dr. Umesh Kumar Sapra2 Dr. Prahlad Kumar Prajapati*1
article en

Abstract

Non-Alcoholic Fatty Liver Disease (NAFLD) is a growing global health concern characterized by excessive fat accumulation in the liver without significant alcohol consumption. It encompasses a spectrum ranging from simple steatosis to non-alcoholic steatohepatitis (NASH), potentially progressing to cirrhosis and hepatocellular carcinoma. Modern therapeutic options for NAFLD are limited and primarily focus on lifestyle modification, highlighting the need for effective alternative treatments. Ayurveda, the ancient Indian system of medicine, offers a holistic approach to liver disorders, with several classical formulations reputed for their hepatoprotective and metabolic regulatory effects. Among these, Sudarshan Ghanvati and Arogyavardhani Vati have been traditionally employed for managing liver dysfunction and associated metabolic imbalances. This review compares the efficacy, pharmacodynamics, and clinical applications of Sudarshan Ghanvati and Arogyavardhani Vati in the management of NAFLD. Sudarshan Ghanvati, known for its Deepana (digestive stimulant), Pachana (digestive), and Pittashamak (anti-inflammatory) properties, aids in improving metabolism and reducing hepatic inflammation. Arogyavardhani Vati, containing a combination of herbs and mineral preparations, exhibits potent hepatoprotective, antioxidant, and lipid-lowering effects. Both formulations contribute to detoxification and metabolic homeostasis, albeit through differing mechanisms. By analyzing classical texts, clinical studies, and pharmacological data, this review highlights their therapeutic potential and safety profiles. It suggests that integrating these Ayurvedic formulations could provide a complementary approach to NAFLD management, warranting further clinical trials for standardized protocols and validation.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 5%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.